WP
Woodline Partners Portfolio holdings
AUM
$18.9B
1-Year Return
23.37%
This Quarter Return
-0.99%
1 Year Return
+23.37%
3 Year Return
+125.78%
5 Year Return
+185.63%
10 Year Return
–
AUM
$10.4B
AUM Growth
-$393M
(-3.6%)
Cap. Flow
-$94.4M
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
14.8%
Holding
711
New
186
Increased
182
Reduced
155
Closed
168
Top Buys
| 1 |
Marsh & McLennan
MMC
|
$123M |
| 2 |
Electronic Arts
EA
|
$102M |
| 3 |
Chord Energy
CHRD
|
$100M |
| 4 |
Quest Diagnostics
DGX
|
$89.2M |
| 5 |
Sensata Technologies
ST
|
$73.8M |
Top Sells
| 1 |
Analog Devices
ADI
|
$138M |
| 2 |
Avnet
AVT
|
$131M |
| 3 |
ERF
Enerplus Corporation
ERF
|
$110M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
$73.5M |
| 5 |
Amazon
AMZN
|
$73.3M |
Sector Composition
| 1 | Healthcare | 42.62% |
| 2 | Technology | 19.87% |
| 3 | Energy | 7.88% |
| 4 | Industrials | 7.25% |
| 5 | Financials | 7.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WBTN
126
WEBTOON Entertainment Inc. Common Stock
WBTN
$1.9B
| $26M | 0.25% |
+1,139,200
| New | +$26M |
|
|
NVEI
127
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $25.9M | 0.25% |
+800,000
| New | +$25.9M |
|
128
Alkermes
ALKS
$4.77B
| $25.8M | 0.25% |
1,071,071
+1,231
| +0.1% | +$29.7K |
|
129
Uber
UBER
$192B
| $25.6M | 0.24% |
+352,732
| New | +$25.6M |
|
130
Axsome Therapeutics
AXSM
$6.21B
| $25.6M | 0.24% |
318,011
-42,117
| -12% | -$3.39M |
|
131
Select Medical
SEM
$1.61B
| $25.4M | 0.24% |
1,345,325
+728,508
| +118% | +$13.8M |
|
132
Textron
TXT
$14.5B
| $25.4M | 0.24% |
+295,691
| New | +$25.4M |
|
133
Check Point Software Technologies
CHKP
$20.5B
| $25.3M | 0.24% |
153,230
+95,219
| +164% | +$15.7M |
|
134
TG Therapeutics
TGTX
$5.06B
| $25.3M | 0.24% |
1,419,534
+14,937
| +1% | +$266K |
|
135
Starbucks
SBUX
$98.9B
| $25.2M | 0.24% |
323,296
+104,886
| +48% | +$8.17M |
|
136
Edwards Lifesciences
EW
$47.5B
| $24.6M | 0.23% |
266,078
-215,848
| -45% | -$19.9M |
|
137
Icon
ICLR
$13.7B
| $24.4M | 0.23% |
77,993
-75,969
| -49% | -$23.8M |
|
138
argenx
ARGX
$44.9B
| $24.4M | 0.23% |
+56,771
| New | +$24.4M |
|
139
BridgeBio Pharma
BBIO
$9.91B
| $24.1M | 0.23% |
949,570
+248,821
| +36% | +$6.3M |
|
140
Kenvue
KVUE
$39.4B
| $23.9M | 0.23% |
+1,312,745
| New | +$23.9M |
|
141
HealthEquity
HQY
$8.42B
| $23.7M | 0.23% |
+275,196
| New | +$23.7M |
|
|
HES
142
DELISTED
Hess
HES
| $23.6M | 0.23% |
160,071
-240,001
| -60% | -$35.4M |
|
143
Masimo
MASI
$7.77B
| $23.4M | 0.22% |
185,990
+132,844
| +250% | +$16.7M |
|
144
Ball Corp
BALL
$13.7B
| $23.4M | 0.22% |
+389,999
| New | +$23.4M |
|
145
International Flavors & Fragrances
IFF
$16.8B
| $23.2M | 0.22% |
243,692
+155,007
| +175% | +$14.8M |
|
146
Brown & Brown
BRO
$31.5B
| $23.2M | 0.22% |
+259,029
| New | +$23.2M |
|
147
Dynatrace
DT
$15B
| $23.1M | 0.22% |
515,300
+101,669
| +25% | +$4.55M |
|
|
HCP
148
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $22.9M | 0.22% |
+680,000
| New | +$22.9M |
|
149
Expedia Group
EXPE
$26.8B
| $22.5M | 0.21% |
178,721
-368,413
| -67% | -$46.4M |
|
150
Estee Lauder
EL
$31.5B
| $22.4M | 0.21% |
210,327
-41,991
| -17% | -$4.47M |
|